Skip to main content
Top
Published in: Transplantation Research 1/2013

Open Access 01-12-2013 | Review

Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs

Authors: Diana F Anthony, Paul G Shiels

Published in: Transplantation Research | Issue 1/2013

Login to get access

Abstract

Stem cells have been studied for many years for their potential to repair damaged organs in the human body. Although many different mechanisms have been suggested as to how stem cells may initiate and facilitate repair processes, much remains unknown. Recently, there has been considerable interest in the idea that stem cells may exert their effects in vivo via paracrine actions. This could involve the release of cytokines, growth factors or secreted extracellular vesicles. This article reviews the role that paracrine actions may play in tissue regeneration. In particular, it considers how microvesicles, as a mediator or modulator of paracrine action, can be exploited as a tool for non-cell-based therapies in regenerative medicine.
Appendix
Available only for authorised users
Literature
1.
go back to reference Till JE, McCulloch EA: Direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961, 14: 213-222. 10.2307/3570892.CrossRefPubMed Till JE, McCulloch EA: Direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 1961, 14: 213-222. 10.2307/3570892.CrossRefPubMed
2.
go back to reference Becker AJ, McCulloch EA, Till JE: Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963, 197: 452-2. 10.1038/197452a0.CrossRefPubMed Becker AJ, McCulloch EA, Till JE: Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963, 197: 452-2. 10.1038/197452a0.CrossRefPubMed
3.
go back to reference Mironov V, Visconti RP, Markwald RR: What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin Biol Ther. 2004, 4: 773-781. 10.1517/14712598.4.6.773.CrossRefPubMed Mironov V, Visconti RP, Markwald RR: What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin Biol Ther. 2004, 4: 773-781. 10.1517/14712598.4.6.773.CrossRefPubMed
4.
go back to reference Haseltine W: Regenerative medicine 2003: an overview. J Regen Med. 2003, 4: 15-18. Haseltine W: Regenerative medicine 2003: an overview. J Regen Med. 2003, 4: 15-18.
5.
go back to reference Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998, 279: 1528-1530. 10.1126/science.279.5356.1528.CrossRefPubMed Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F: Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998, 279: 1528-1530. 10.1126/science.279.5356.1528.CrossRefPubMed
6.
go back to reference Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.CrossRefPubMed Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.CrossRefPubMed
7.
go back to reference Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007, 292: F1626-F1635. 10.1152/ajprenal.00339.2006.CrossRefPubMed Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C: Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007, 292: F1626-F1635. 10.1152/ajprenal.00339.2006.CrossRefPubMed
8.
go back to reference Chen JS, Wong VW, Gurtner GC: Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immuno. 2012, 3: 1-9. Chen JS, Wong VW, Gurtner GC: Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front Immuno. 2012, 3: 1-9.
9.
go back to reference DeSantiago J, Bare DJ, Semenov I, Minshall RD, Greenen DL, Wolska BM, Banach K: Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signalling from mesenchymal stem cells. J Moll Cell Cardiol. 2012, 52: 1249-1256. 10.1016/j.yjmcc.2012.03.008.CrossRef DeSantiago J, Bare DJ, Semenov I, Minshall RD, Greenen DL, Wolska BM, Banach K: Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signalling from mesenchymal stem cells. J Moll Cell Cardiol. 2012, 52: 1249-1256. 10.1016/j.yjmcc.2012.03.008.CrossRef
10.
go back to reference James AW, Levi B, Commons GW, Glotzbach J, Longaker MT: Paracrine interaction between adipose-derived mesenchymal cells. Plast Recontr Surg. 2010, 126: 806-821. 10.1097/PRS.0b013e3181e5f81a.CrossRef James AW, Levi B, Commons GW, Glotzbach J, Longaker MT: Paracrine interaction between adipose-derived mesenchymal cells. Plast Recontr Surg. 2010, 126: 806-821. 10.1097/PRS.0b013e3181e5f81a.CrossRef
11.
go back to reference Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ: Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011, 50: 280-289. 10.1016/j.yjmcc.2010.08.005.PubMedCentralCrossRefPubMed Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ: Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011, 50: 280-289. 10.1016/j.yjmcc.2010.08.005.PubMedCentralCrossRefPubMed
12.
go back to reference Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularisation of myocardial ischemia. Circulation. 2003, 107: 461-468. 10.1161/01.CIR.0000046450.89986.50.CrossRefPubMed Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C: Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularisation of myocardial ischemia. Circulation. 2003, 107: 461-468. 10.1161/01.CIR.0000046450.89986.50.CrossRefPubMed
13.
go back to reference Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003, 114: 763-776. 10.1016/S0092-8674(03)00687-1.CrossRefPubMed Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003, 114: 763-776. 10.1016/S0092-8674(03)00687-1.CrossRefPubMed
14.
go back to reference Shiels PG, MacIntyre A, Chen D, Dorling A, Deardon D, Subrimaniam M: IV administration of adult stem cells mitigates STZ induced diabetes in a xenotransplant model. American J Transplant. 2005, 5: 369- Shiels PG, MacIntyre A, Chen D, Dorling A, Deardon D, Subrimaniam M: IV administration of adult stem cells mitigates STZ induced diabetes in a xenotransplant model. American J Transplant. 2005, 5: 369-
15.
go back to reference Stevenson KS, McGlynn L, Hoghe M, McLinden H, George WD, Davies RW, Shiels PG: Isolation, characterization and differentiation of Thy1.1-sorted pancreatic adult progenitor cell populations. Stem Cells Dev. 2009, 18: 1389-1398. 10.1089/scd.2008.0301.CrossRefPubMed Stevenson KS, McGlynn L, Hoghe M, McLinden H, George WD, Davies RW, Shiels PG: Isolation, characterization and differentiation of Thy1.1-sorted pancreatic adult progenitor cell populations. Stem Cells Dev. 2009, 18: 1389-1398. 10.1089/scd.2008.0301.CrossRefPubMed
16.
go back to reference Stevenson K, Chen D, MacIntyre A, McGlynn LM, Montague P, Charif R, Subramaniam M, George WD, Payne AP, Davies RW, Dorling A, Shiels PG: Pancreatic-derived Pathfinder cells enable regeneration of critically damaged adult pancreatic tissue and completely reverse streptozotocin-induced diabetes. Rejuv Res. 2011, 14: 163-171. 10.1089/rej.2010.1099.CrossRef Stevenson K, Chen D, MacIntyre A, McGlynn LM, Montague P, Charif R, Subramaniam M, George WD, Payne AP, Davies RW, Dorling A, Shiels PG: Pancreatic-derived Pathfinder cells enable regeneration of critically damaged adult pancreatic tissue and completely reverse streptozotocin-induced diabetes. Rejuv Res. 2011, 14: 163-171. 10.1089/rej.2010.1099.CrossRef
17.
go back to reference McGlynn LM, Eller K, MacDonald A, Macintyre A, Russel D, Koppelstaetter C, Davies RW, Shiels PG: Pathfinder cells provide a novel therapeutic intervention for acute kidney injury. Rejuv Res. 2013, 16: 11-20. 10.1089/rej.2012.1350.CrossRef McGlynn LM, Eller K, MacDonald A, Macintyre A, Russel D, Koppelstaetter C, Davies RW, Shiels PG: Pathfinder cells provide a novel therapeutic intervention for acute kidney injury. Rejuv Res. 2013, 16: 11-20. 10.1089/rej.2012.1350.CrossRef
18.
go back to reference Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature. 2001, 410: 701-705. 10.1038/35070587.CrossRefPubMed Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature. 2001, 410: 701-705. 10.1038/35070587.CrossRefPubMed
19.
go back to reference Kajstura J, Marcello R, Whang B, Cascapera S, Hosoda T, Bearzi C, Nursynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005, 96: 127-137.CrossRefPubMed Kajstura J, Marcello R, Whang B, Cascapera S, Hosoda T, Bearzi C, Nursynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P: Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005, 96: 127-137.CrossRefPubMed
20.
go back to reference Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002, 416: 542-545. 10.1038/nature730.CrossRefPubMed Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002, 416: 542-545. 10.1038/nature730.CrossRefPubMed
21.
go back to reference Nygren JM, Jovinge S, Breitback M, Säwén P, Röll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SEW: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Med. 2004, 10: 494-501. 10.1038/nm1040.CrossRefPubMed Nygren JM, Jovinge S, Breitback M, Säwén P, Röll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SEW: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Med. 2004, 10: 494-501. 10.1038/nm1040.CrossRefPubMed
22.
go back to reference Przybyt E, Krenning G, Brinker MGL, Harmsen C: Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. J Transl Med. 2013, 11: 39-10.1186/1479-5876-11-39.PubMedCentralCrossRefPubMed Przybyt E, Krenning G, Brinker MGL, Harmsen C: Adipose stromal cells primed with hypoxia and inflammation enhance cardiomyocyte proliferation rate in vitro through STAT3 and Erk1/2. J Transl Med. 2013, 11: 39-10.1186/1479-5876-11-39.PubMedCentralCrossRefPubMed
23.
go back to reference Burchfield JS, Dimmeler S: Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogen Tissue Repair. 2008, 1: 4-10.1186/1755-1536-1-4.CrossRef Burchfield JS, Dimmeler S: Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogen Tissue Repair. 2008, 1: 4-10.1186/1755-1536-1-4.CrossRef
24.
go back to reference Liu J, Narsinh KH, Lan F, Wang L, Nguyen PK, Hu S, Lee A, Han L, Gong Y, Huang M, Nag D, Rosenberg J, Chouldechova A, Robbins RC, Wu JC: Early stem cell engraftment predicts late cardiac functional recovery. Circ Cardiovasc Imaging. 2012, 5: 481-490. 10.1161/CIRCIMAGING.111.969329.PubMedCentralCrossRefPubMed Liu J, Narsinh KH, Lan F, Wang L, Nguyen PK, Hu S, Lee A, Han L, Gong Y, Huang M, Nag D, Rosenberg J, Chouldechova A, Robbins RC, Wu JC: Early stem cell engraftment predicts late cardiac functional recovery. Circ Cardiovasc Imaging. 2012, 5: 481-490. 10.1161/CIRCIMAGING.111.969329.PubMedCentralCrossRefPubMed
25.
26.
go back to reference Luan Y, Zhang X, Kong F, Cheng GH, Qi TG, Zhang ZH: Mesenchymal stem cell prevention of vascular remodelling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol. 2012, 14: 432-437. 10.1016/j.intimp.2012.08.001.CrossRefPubMed Luan Y, Zhang X, Kong F, Cheng GH, Qi TG, Zhang ZH: Mesenchymal stem cell prevention of vascular remodelling in high flow-induced pulmonary hypertension through a paracrine mechanism. Int Immunopharmacol. 2012, 14: 432-437. 10.1016/j.intimp.2012.08.001.CrossRefPubMed
27.
go back to reference Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M: Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012, 492: 376-381. 10.1038/nature11739.CrossRefPubMed Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M: Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012, 492: 376-381. 10.1038/nature11739.CrossRefPubMed
28.
go back to reference He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004, 5: 522-531. 10.1038/nrg1379.CrossRefPubMed He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004, 5: 522-531. 10.1038/nrg1379.CrossRefPubMed
29.
go back to reference Cantaluppi V, Biancone L, Quercia A, Deregibus MC, Segoloni G, Camussi G: Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis. 2013, 61: 300-309. 10.1053/j.ajkd.2012.05.027.CrossRefPubMed Cantaluppi V, Biancone L, Quercia A, Deregibus MC, Segoloni G, Camussi G: Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis. 2013, 61: 300-309. 10.1053/j.ajkd.2012.05.027.CrossRefPubMed
30.
go back to reference Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005, 289: F31-F42. 10.1152/ajprenal.00007.2005.CrossRefPubMed Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005, 289: F31-F42. 10.1152/ajprenal.00007.2005.CrossRefPubMed
31.
go back to reference Chen L, Tredget EE, Wu PYG, Wu Y: Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008, 3: e1886-10.1371/journal.pone.0001886.PubMedCentralCrossRefPubMed Chen L, Tredget EE, Wu PYG, Wu Y: Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008, 3: e1886-10.1371/journal.pone.0001886.PubMedCentralCrossRefPubMed
32.
go back to reference Jackson WM, Nesti LJ, Tuan RS: Concise review: Clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cell Trans Med. 2012, 1: 44-50. 10.5966/sctm.2011-0024.CrossRef Jackson WM, Nesti LJ, Tuan RS: Concise review: Clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cell Trans Med. 2012, 1: 44-50. 10.5966/sctm.2011-0024.CrossRef
33.
go back to reference Barcelos LS, Duplaa C, Krӓnkel N, Graiani G, Invercini G, Katare R, Siragusa M, Meloni M, Campesi I, Monica M, Simm A, Campagnolo P, Mangialardi G, Stevanato L, Alessandri G, Emanueli C, Madeddu P: Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signalling. Circ Res. 2009, 104: 1095-1102. 10.1161/CIRCRESAHA.108.192138.PubMedCentralCrossRefPubMed Barcelos LS, Duplaa C, Krӓnkel N, Graiani G, Invercini G, Katare R, Siragusa M, Meloni M, Campesi I, Monica M, Simm A, Campagnolo P, Mangialardi G, Stevanato L, Alessandri G, Emanueli C, Madeddu P: Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signalling. Circ Res. 2009, 104: 1095-1102. 10.1161/CIRCRESAHA.108.192138.PubMedCentralCrossRefPubMed
34.
go back to reference Lee SH, Jin SY, Song JS, Seo KK, Cho KH: Paracrine effects of adipose-derived stem cells on keratinocytes and dermal fibroblasts. Ann Dermatol. 2012, 24: 136-143. 10.5021/ad.2012.24.2.136.PubMedCentralCrossRefPubMed Lee SH, Jin SY, Song JS, Seo KK, Cho KH: Paracrine effects of adipose-derived stem cells on keratinocytes and dermal fibroblasts. Ann Dermatol. 2012, 24: 136-143. 10.5021/ad.2012.24.2.136.PubMedCentralCrossRefPubMed
35.
go back to reference Quertainmont R, Cantinieaux D, Botman O, Eid S, Schoenen J, Franzen R: Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One. 2012, 7: e39500-10.1371/journal.pone.0039500.PubMedCentralCrossRefPubMed Quertainmont R, Cantinieaux D, Botman O, Eid S, Schoenen J, Franzen R: Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One. 2012, 7: e39500-10.1371/journal.pone.0039500.PubMedCentralCrossRefPubMed
36.
go back to reference Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB: Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical implications. Stem Cells. 2011, 29: 169-178. 10.1002/stem.570.PubMedCentralCrossRefPubMed Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB: Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical implications. Stem Cells. 2011, 29: 169-178. 10.1002/stem.570.PubMedCentralCrossRefPubMed
38.
go back to reference Cocucci E, Rachetti G, Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009, 19: 43-51. 10.1016/j.tcb.2008.11.003.CrossRefPubMed Cocucci E, Rachetti G, Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009, 19: 43-51. 10.1016/j.tcb.2008.11.003.CrossRefPubMed
39.
go back to reference Lee Y, Andaloussi SEL, Wood MJA: Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012, 21: R125-R134. 10.1093/hmg/dds317.CrossRefPubMed Lee Y, Andaloussi SEL, Wood MJA: Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012, 21: R125-R134. 10.1093/hmg/dds317.CrossRefPubMed
40.
go back to reference Fleissner F, Goerzig Y, Haverich A, Thum T: Microvesicles as a novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant. 2012, 12: 289-297. 10.1111/j.1600-6143.2011.03790.x.CrossRefPubMed Fleissner F, Goerzig Y, Haverich A, Thum T: Microvesicles as a novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant. 2012, 12: 289-297. 10.1111/j.1600-6143.2011.03790.x.CrossRefPubMed
41.
go back to reference Ohno S, Ishikawa A, Kuroda M: Roles of exosomes and microvesicles in disease pathogenesis. Adv Drug Deliv Rev. 2013, 65: 398-401. 10.1016/j.addr.2012.07.019.CrossRefPubMed Ohno S, Ishikawa A, Kuroda M: Roles of exosomes and microvesicles in disease pathogenesis. Adv Drug Deliv Rev. 2013, 65: 398-401. 10.1016/j.addr.2012.07.019.CrossRefPubMed
42.
go back to reference Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJP, Hole P, Carr B, Redman CWG, Harris AL, Dobson PJ, Harrison P, Sargent IL: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed. 2011, 7: 780-788.CrossRef Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJP, Hole P, Carr B, Redman CWG, Harris AL, Dobson PJ, Harrison P, Sargent IL: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed. 2011, 7: 780-788.CrossRef
43.
go back to reference Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C: Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010, 123: 1603-1611. 10.1242/jcs.064386.PubMedCentralCrossRefPubMed Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C: Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010, 123: 1603-1611. 10.1242/jcs.064386.PubMedCentralCrossRefPubMed
44.
go back to reference Akers JC, Gonda D, Kim R, Carter BS, Chen CC: Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013, 113: 1-11. 10.1007/s11060-013-1084-8.CrossRefPubMed Akers JC, Gonda D, Kim R, Carter BS, Chen CC: Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013, 113: 1-11. 10.1007/s11060-013-1084-8.CrossRefPubMed
45.
go back to reference Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009, 20: 1053-1067. 10.1681/ASN.2008070798.PubMedCentralCrossRefPubMed Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 2009, 20: 1053-1067. 10.1681/ASN.2008070798.PubMedCentralCrossRefPubMed
46.
go back to reference Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G: Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012, 82: 412-427. 10.1038/ki.2012.105.CrossRefPubMed Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G: Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012, 82: 412-427. 10.1038/ki.2012.105.CrossRefPubMed
47.
go back to reference Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G: Microvesicles derived from human adult mesenchymal stem cells protect against ischaemic-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011, 26: 1474-1483. 10.1093/ndt/gfr015.CrossRefPubMed Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, Camussi G: Microvesicles derived from human adult mesenchymal stem cells protect against ischaemic-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011, 26: 1474-1483. 10.1093/ndt/gfr015.CrossRefPubMed
48.
go back to reference Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C, Camussi G: Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 2010, 14: 1605-1618.PubMedCentralCrossRefPubMed Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C, Camussi G: Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 2010, 14: 1605-1618.PubMedCentralCrossRefPubMed
49.
go back to reference Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, Wang YQ, Cao XF, Lv J, Xiao FJ, Yang Y, Guo ZK: Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cell Dev. 2012, 21: 3289-3297. 10.1089/scd.2012.0095.CrossRef Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, Wang YQ, Cao XF, Lv J, Xiao FJ, Yang Y, Guo ZK: Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cell Dev. 2012, 21: 3289-3297. 10.1089/scd.2012.0095.CrossRef
50.
go back to reference Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A, Kourembanas S: Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012, 26: 2601-2611.CrossRef Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A, Kourembanas S: Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012, 26: 2601-2611.CrossRef
51.
go back to reference Zuo S, Jones WK, Li H, He Z, Pasha Z, Yang Y, Wang Y, Fan GC, Ashraf M, Xu M: Paracrine effect of Wnt11 overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev. 2012, 21: 598-608. 10.1089/scd.2011.0071.PubMedCentralCrossRefPubMed Zuo S, Jones WK, Li H, He Z, Pasha Z, Yang Y, Wang Y, Fan GC, Ashraf M, Xu M: Paracrine effect of Wnt11 overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev. 2012, 21: 598-608. 10.1089/scd.2011.0071.PubMedCentralCrossRefPubMed
52.
go back to reference Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005, 11: 367-368. 10.1038/nm0405-367.CrossRefPubMed Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005, 11: 367-368. 10.1038/nm0405-367.CrossRefPubMed
53.
go back to reference Iglesias DM, El-Kares R, Taranta A, Bellomo F, Emma F, Besouw M, Levtchenko E, Toelen J, van den Heuvel L, Chu LL, Zhao J, Young YK, Eliopoulos N, Goodyer P: Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cysteine accumulation in vitro. PLoS One. 2012, 7: e42840-10.1371/journal.pone.0042840.PubMedCentralCrossRefPubMed Iglesias DM, El-Kares R, Taranta A, Bellomo F, Emma F, Besouw M, Levtchenko E, Toelen J, van den Heuvel L, Chu LL, Zhao J, Young YK, Eliopoulos N, Goodyer P: Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cysteine accumulation in vitro. PLoS One. 2012, 7: e42840-10.1371/journal.pone.0042840.PubMedCentralCrossRefPubMed
54.
go back to reference Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, Ratajczak J: Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?. Leukemia. 2012, 26: 1166-1173. 10.1038/leu.2011.389.CrossRefPubMed Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, Ratajczak J: Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?. Leukemia. 2012, 26: 1166-1173. 10.1038/leu.2011.389.CrossRefPubMed
55.
go back to reference Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LEJ, Berman D, Czer LSC, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012, 379: 895-904. 10.1016/S0140-6736(12)60195-0.PubMedCentralCrossRefPubMed Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LEJ, Berman D, Czer LSC, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012, 379: 895-904. 10.1016/S0140-6736(12)60195-0.PubMedCentralCrossRefPubMed
56.
go back to reference Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011, 378: 1847-1857. 10.1016/S0140-6736(11)61590-0.PubMedCentralCrossRefPubMed Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011, 378: 1847-1857. 10.1016/S0140-6736(11)61590-0.PubMedCentralCrossRefPubMed
Metadata
Title
Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs
Authors
Diana F Anthony
Paul G Shiels
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Transplantation Research / Issue 1/2013
Electronic ISSN: 2047-1440
DOI
https://doi.org/10.1186/2047-1440-2-10

Other articles of this Issue 1/2013

Transplantation Research 1/2013 Go to the issue